In summary, our findings proposed a comprehensive view of the oncogenic role of FBXO5 in multiple kinds of cancers and suggested that FBXO5 might function as a viable indicator for predicting clinical prognosis and immune therapy response in cancer patients. Here, FBXO5 is linked to cancer.